Solvonis Therapeutics (LSE:SVNS) Inventories, Raw Materials & Components: £0.00 Mil (As of Dec. 2025)


What is Solvonis Therapeutics Inventories, Raw Materials & Components?

Solvonis Therapeutics LSE:SVNS -1.82% Inventories, Raw Materials & Components is £0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Solvonis Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2025 was £0.00 Mil.

Solvonis Therapeutics's annual raw materials declined from Dec. 2023 (£0.05 Mil) to Dec. 2024 (£0.00 Mil) but then stayed the same from Dec. 2024 (£0.00 Mil) to Dec. 2025 (£0.00 Mil).

Solvonis Therapeutics Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Solvonis Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solvonis Therapeutics Inventories, Raw Materials & Components Chart

Solvonis Therapeutics Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 0.00 0.12 0.05 0.00 0.00

Solvonis Therapeutics Semi-Annual Data
May18 May19 May20 May21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.00 0.00 0.00 0.00

Solvonis Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of £0.00 Mil mean?
Solvonis Therapeutics (LSE:SVNS) has a Inventories, Raw Materials & Components of £0.00 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Solvonis Therapeutics and its competitors.
Is Solvonis Therapeutics' Inventories, Raw Materials & Components too high?
Solvonis Therapeutics' current Inventories, Raw Materials & Components is £0.00 Mil.
How does Solvonis Therapeutics' Inventories, Raw Materials & Components compare to GEV and ETN?
Solvonis Therapeutics' Inventories, Raw Materials & Components of £0.00 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for an Industrial Products company?
A good Inventories, Raw Materials & Components depends on the Industrial Products industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Solvonis Therapeutics and its competitors. Solvonis Therapeutics's current Inventories, Raw Materials & Components is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solvonis Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Solvonis Therapeutics (LSE:SVNS) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.00 — trading 91.9% below its estimated fair value. The current Inventories, Raw Materials & Components is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Solvonis Therapeutics (LSE:SVNS), the current Inventories, Raw Materials & Components is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Solvonis Therapeutics Business Description

Other Exchanges J4I:Germany
Address Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Solvonis Therapeutics PLC focuses on the development of therapeutic solutions. The company is engaged in the development of novel small-molecule therapeutics for high-burden central nervous system ("CNS") disorders focusing on addiction and psychiatry. The products in company's pipeline include SVN-001, SVN-002, SVN-015. SVN-114, and others.